We are live on ! Find out more
KC

Kryger Capital Portfolio holdings

AUM $1.41B
1-Year Est. Return 86.31%
This Fund
S&P 500
This Quarter Est. Return
+27.15%
1 Year Est. Return
+86.31%
3 Year Est. Return
+420.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$866M
AUM Growth
+$325M
Cap. Flow
+$232M
Cap. Flow %
26.85%
Top 10 Hldgs %
84.61%
Holding
42
New
26
Increased
2
Reduced
4
Closed
10

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$100M
2
NSC icon
Norfolk Southern
NSC
+$91.4M
3
CYBR
CyberArk
CYBR
+$86.6M
4
COOP
Mr. Cooper
COOP
+$74.9M
5
MRUS
Merus
MRUS
+$68.6M

Top Sells

Rank Stock Value
1
HES
Hess
HES
+$143M
2
AZEK
The AZEK Co
AZEK
+$107M
3
SWTX
SpringWorks Therapeutics
SWTX
+$36M
4
CHX
ChampionX
CHX
+$35.1M
5
SKX
Skechers
SKX
+$32.6M

Sector Composition

Rank Sector Weight
1 Healthcare 29.25%
2 Technology 17.97%
3 Industrials 16.99%
4 Communication Services 14.45%
5 Financials 10.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FCRS.U
26
FutureCrest Acquisition Corp Units
FCRS.U
$530K 0.06%
+50,000
New +$525K
CEPT
27
DELISTED
Cantor Equity Partners II
CEPT
$269K 0.03%
25,558
+208
+0.8% +$2.24K
CEPF
28
Cantor Equity Partners IV
CEPF
$597M
$258K 0.03%
+25,349
New +$257K
BLZRU
29
Trailblazer Acquisition Corp Unit
BLZRU
$205M
$256K 0.03%
+25,000
New +$253K
FIGXU
30
FIGX Capital Acquisition Corp Units
FIGXU
$254K 0.03%
+25,169
New +$253K
CAEP
31
DELISTED
Cantor Equity Partners III
CAEP
$104K 0.01%
+10,040
New +$105K
OBAWU
32
Oxley Bridge Acquisition Ltd Unit
OBAWU
$101K 0.01%
+10,090
New +$101K
AZEK
33
DELISTED
The AZEK Co
AZEK
– –
-1,967,510
Closed -$107M
BPMC
34
DELISTED
Blueprint Medicines
BPMC
– –
-248,219
Closed -$31.8M
CHX
35
DELISTED
ChampionX
CHX
– –
-1,414,874
Closed -$35.1M
EVRI
36
DELISTED
Everi Holdings
EVRI
– –
-714,387
Closed -$10.2M
HES
37
DELISTED
Hess
HES
– –
-1,033,178
Closed -$143M
MAG
38
DELISTED
MAG Silver
MAG
– –
-561,004
Closed -$11.9M
SGRY icon
39
Surgery Partners
SGRY
$1.98B
– –
-100,920
Closed -$2.24M
SPR
40
DELISTED
Spirit AeroSystems
SPR
– –
-109,704
Closed -$4.19M
SPTN
41
DELISTED
SpartanNash
SPTN
– –
-168,540
Closed -$4.46M
SWTX
42
DELISTED
SpringWorks Therapeutics
SWTX
– –
-765,522
Closed -$36M
1
2

Similar funds

EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.41B AUM 18.71% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
QC
Quent Capital New York $1.41B AUM 22.9% 1-Year Est. Return
BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
KCM
Kanawha Capital Management Richmond, Virginia $1.42B AUM 18.26% 1-Year Est. Return
EA
Efficient Advisors Mason, Ohio $1.41B AUM 13.81% 1-Year Est. Return

Kryger Capital's Q3 2025 Portfolio in Review

As of Q3 2025, Kryger Capital held 42 positions worth $866M, up 60% from $540M the previous quarter. Its ten largest holdings account for 85% of the portfolio.

Kryger Capital deployed $232M of net new capital in Q3 2025, opening 26 new positions and adding to 2 existing holdings. Its largest new stake was Verona Pharma: 962,341 shares worth $103M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Skechers, an estimated $32.6M trimmed.

  • Kryger Capital's largest Q3 2025 buy was Verona Pharma: 962,341 shares worth $103M.
  • Kryger Capital added most to Frontier Communications in Q3 2025, an estimated $10.2M increase.
  • Kryger Capital's biggest Q3 2025 reduction was Skechers, cutting an estimated $32.6M.
  • Kryger Capital fully exited Hess in Q3 2025, selling an estimated $143M.
  • Kryger Capital's ten largest holdings make up 85% of its $866M portfolio in Q3 2025.
  • Kryger Capital opened 26 new positions and closed 10 in Q3 2025.
  • Kryger Capital's portfolio value rose 60% quarter-over-quarter to $866M.

Based on Kryger Capital's 13F filing for Q3 2025, filed 14 Nov 2025.